Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Haematologica
|
February 9, 2006
Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors
Kaye L Johnston, John P Farnen, Brian R Manske, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
November 11, 2008
Ascorbic acid deficiency in bariatric surgical population
Kevin P Riess, John P Farnen, Pamela J Lambert, et al.
Journal of the American College of Surgeons
|
December 10, 2013
Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis
Kosisochi M Obinwanne, Kyla A Fredrickson, Michelle A Mathiason, et al.
European Journal of Haematology
|
January 19, 2005
Human cyclic thrombocytopenia and Anaplasma spp. infection
Ronald S Go, Steven D Lovrich, Steven M Callister, et al.
American Journal of Hematology
|
December 22, 2018
Severe, prolonged thrombocytopenia in a patient sensitive to exenatide
Yazhini Vallatharasu, Yacki Hayashi-Tanner, Peter J Polewski, et al.
Annals of Hematology
|
January 15, 2008
Circulating endothelial cells in patients with chronic lymphocytic leukemia
Ronald S Go, Dean A Jobe, Krista E Asp, et al.
Leukemia & Lymphoma
|
December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)
Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Cancer
|
June 17, 2015
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, et al.
Cancer
|
March 21, 2014
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
Chi Young Ok, Zijun Y Xu-Monette, Alexandar Tzankov, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2013
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Haematologica
|
February 9, 2006
Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors
Kaye L Johnston, John P Farnen, Brian R Manske, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
November 11, 2008
Ascorbic acid deficiency in bariatric surgical population
Kevin P Riess, John P Farnen, Pamela J Lambert, et al.
Journal of the American College of Surgeons
|
December 10, 2013
Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis
Kosisochi M Obinwanne, Kyla A Fredrickson, Michelle A Mathiason, et al.
European Journal of Haematology
|
January 19, 2005
Human cyclic thrombocytopenia and Anaplasma spp. infection
Ronald S Go, Steven D Lovrich, Steven M Callister, et al.
American Journal of Hematology
|
December 22, 2018
Severe, prolonged thrombocytopenia in a patient sensitive to exenatide
Yazhini Vallatharasu, Yacki Hayashi-Tanner, Peter J Polewski, et al.
Annals of Hematology
|
January 15, 2008
Circulating endothelial cells in patients with chronic lymphocytic leukemia
Ronald S Go, Dean A Jobe, Krista E Asp, et al.
Leukemia & Lymphoma
|
December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)
Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Cancer
|
June 17, 2015
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, et al.
Cancer
|
March 21, 2014
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
Chi Young Ok, Zijun Y Xu-Monette, Alexandar Tzankov, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2013
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, et al.
Page
of 2